Identification Generic Name (2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium DrugBank Accession Number DB03881 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium (DB03881) ×  Close Weight Average: 297.353  Monoisotopic: 297.10213612  Chemical Formula C 12 H 17 N 4 O 3 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Purine nucleotide phosphorylase, putative Not Available Plasmodium falciparum (isolate 3D7) U Purine nucleoside phosphorylase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as pyrrolopyrimidines. These are compounds containing a pyrrolopyrimidine moiety, which consists of a pyrrole ring fused to a pyrimidine. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Pyrrolopyrimidines Sub Class Not Available Direct Parent Pyrrolopyrimidines Alternative Parents Pyrimidones  /  Aralkylamines  /  Substituted pyrroles  /  Vinylogous amides  /  Quaternary ammonium salts  /  Pyrrolidines  /  Heteroaromatic compounds  /  1,2-aminoalcohols  /  Secondary alcohols  /  1,2-diols  /  Sulfenyl compounds  /  Azacyclic compounds  /  Dialkylamines  /  Dialkylthioethers  /  Organic oxides  /  Hydrocarbon derivatives  /  Organic cations 
 
 
  show 7 more Substituents 1,2-aminoalcohol  /  1,2-diol  /  Alcohol  /  Amine  /  Aralkylamine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Dialkylthioether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Organic cation  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organosulfur compound  /  Pyrimidine  /  Pyrimidone  /  Pyrrole  /  Pyrrolidine  /  Pyrrolopyrimidine  /  Quaternary ammonium salt  /  Secondary alcohol  /  Secondary aliphatic amine  /  Secondary amine  /  Substituted pyrrole  /  Sulfenyl compound  /  Thioether  /  Vinylogous amide 
 
 
  show 20 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors dihydroxypyrrolidine, pyrrolopyrimidine ( CHEBI:44290 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key CEGIKIXYDFDYDN-RXDXJJGDSA-O InChI InChI=1S/C12H16N4O3S/c1-20-3-6-10(17)11(18)8(16-6)5-2-13-9-7(5)14-4-15-12(9)19/h2,4,6,8,10-11,13,16-18H,3H2,1H3,(H,14,15,19)/p+1/t6-,8+,10-,11+/m1/s1 IUPAC Name (2S,3R,4S,5S)-3,4-dihydroxy-2-[(methylsulfanyl)methyl]-5-{4-oxo-1H,4H,5H-pyrrolo[3,2-d]pyrimidin-7-yl}pyrrolidin-1-ium SMILES [H]N1C=C([C@H]2[C@H](O)[C@H](O)[C@@H](CSC)[N+]2([H])[H])C2=C1C(=O)N=CN2[H] References General References Not Available External Links PubChem Compound 131704261 PubChem Substance 46506174 ChemSpider 4883415 PDBe Ligand MTI PDB Entries 1q1g Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source logP -0.72 Chemaxon pKa (Strongest Acidic) 12.5 Chemaxon pKa (Strongest Basic) 8.45 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 5 Chemaxon Polar Surface Area 114.32 Å 2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 88.19 m 3 ·mol -1 Chemaxon Polarizability 29.18 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9838 Blood Brain Barrier - 0.835 Caco-2 permeable - 0.7163 P-glycoprotein substrate Substrate 0.6708 P-glycoprotein inhibitor I Non-inhibitor 0.9827 P-glycoprotein inhibitor II Non-inhibitor 0.979 Renal organic cation transporter Non-inhibitor 0.9203 CYP450 2C9 substrate Non-substrate 0.8061 CYP450 2D6 substrate Non-substrate 0.7812 CYP450 3A4 substrate Substrate 0.5428 CYP450 1A2 substrate Non-inhibitor 0.7826 CYP450 2C9 inhibitor Non-inhibitor 0.8315 CYP450 2D6 inhibitor Non-inhibitor 0.8693 CYP450 2C19 inhibitor Non-inhibitor 0.81 CYP450 3A4 inhibitor Non-inhibitor 0.9584 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8782 Ames test Non AMES toxic 0.7057 Carcinogenicity Non-carcinogens 0.9506 Biodegradation Not ready biodegradable 0.9794 Rat acute toxicity 2.4136 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9915 hERG inhibition (predictor II) Non-inhibitor 0.7918    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Purine nucleotide phosphorylase, putative Kind Protein Organism Plasmodium falciparum (isolate 3D7) Pharmacological action Unknown General Function Uridine phosphorylase activity Specific Function Not Available Gene Name Not Available Uniprot ID Q8I3X4 Uniprot Name Purine nucleotide phosphorylase, putative Molecular Weight 26857.88 Da 
 
 
  Details 2.  Purine nucleoside phosphorylase Kind Protein Organism Humans Pharmacological action Unknown General Function Purine-nucleoside phosphorylase activity Specific Function The purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine ... Gene Name PNP Uniprot ID P00491 Uniprot Name Purine nucleoside phosphorylase Molecular Weight 32117.69 Da References Shi W, Ting LM, Kicska GA, Lewandowicz A, Tyler PC, Evans GB, Furneaux RH, Kim K, Almo SC, Schramm VL: Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem. 2004 Apr 30;279(18):18103-6. Epub 2004 Feb 23. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 